LDS/Medical Tests/Interleukin 10 (IL-10)

Interleukin 10 (IL-10)

Interleukin-10 (IL-10) is a critical anti-inflammatory cytokine with potent immunoregulatory functions. Produced primarily by immune cells including monocytes, macrophages, dendritic cells, regulatory T-cells, and B-cells, IL-10 modulates immune responses by suppressing excessive inflammation and preventing chronic autoimmune reactions. Its primary mechanism involves binding to the IL-10 receptor, activating the signal transducer and activator of transcription 3 (STAT3) pathway. This activation induces anti-inflammatory gene expression while inhibiting pro-inflammatory cytokines, effectively balancing the immune response and promoting tissue homeostasis.

IL-10 deficiency or low production is associated with excessive and chronic immune activation, often leading to autoimmune and inflammatory diseases. Low levels of IL-10 have been linked with inflammatory bowel disease, Crohn’s disease, ulcerative colitis, rheumatoid arthritis, psoriasis, multiple sclerosis, type 1 diabetes mellitus, and enhanced rejection risk in organ transplantation due to immune dysregulation.

Conversely, elevated IL-10 levels can occur in chronic infectious conditions (e.g., HIV, tuberculosis, hepatitis B and C infections), malignancies, and sepsis, reflecting the body's attempt to mitigate ongoing systemic inflammation and immune activation. Persistently high IL-10 levels in such conditions may contribute to immune suppression, potentially worsening disease outcomes.

  • As an aid for the diagnosis and monitoring of inflammatory and autoimmune conditions
  • Assessment of disease severity and immune status in chronic infections and malignancies
  • Evaluation of immune status in sepsis or systemic inflammatory response syndrome (SIRS)
  • Monitoring immune responses and rejection risk in transplant patients

Increased IL-10 levels:

  • Chronic infections (HIV, tuberculosis, hepatitis B & C)
  • Malignancies (cancers associated with immune suppression)
  • Sepsis or systemic inflammatory response syndrome (SIRS)

Decreased IL-10 levels:

  • Inflammatory bowel diseases (Crohn’s disease, ulcerative colitis)
  • Autoimmune disorders (rheumatoid arthritis, psoriasis, multiple sclerosis, type 1 diabetes mellitus)
  • Increased risk of transplant rejection due to reduced immune regulation

<2.8 pg/mL

Turbidimetry (Quantitative multiplex bead assay).

Serum (SST tube).

Stability

  • Ambient: 1 hour
  • Refrigerated: unacceptable
  • Frozen: 1 year
C-Reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR), Procalcitonin, Serum Albumin, Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), Tumor Necrosis Factor-alpha (TNF-α), IL-6, and other inflammatory cytokines for comprehensive immune profiling.
1 to 4 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login